SECAUCUS, N.J., March 2, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, ...

By using a mobile app and patient portal called MyQuest, “adult users can prompt the tool to define test names and medical ...

SECAUCUS, N.J., Feb. 2, 2026 /PRNewswire/ --Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel blood test that uses advanced ...

The Global Point-of-Care (POC) Diagnostics Market is projected to expand at a CAGR of 11% through 2028. Growth is being fueled by the rising burden of infectious diseases, increasing demand for rapid ...

Quest Diagnostics (NYSE:DGX) announced on Wednesday that it will roll out a rapid molecular lab test to detect the avian influenza A H5 virus. This initiative is part of an award from the U.S. Centers ...

CHARLESTON, S.C.--(BUSINESS WIRE)--True Diagnostics, Inc. (TrueDx), a leading Point of Care (POC) company, Infectolab Americas (Infectolab), a recently established CLIA laboratory specializing in ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has opened a new, ...

TALLAHASSEE, Fla. — Following an order from Gov. Ron DeSantis, the Florida Department of Health and the Florida Department of Emergency Management are severing all ties with Quest Diagnostics after ...

Researchers at Imperial College London say they have developed a novel lab-on-a-chip infection test that could provide less expensive and faster portable diagnostics. The chip, known as TriSilix, is a ...

"Our Flow Cytometry MRD for Myeloma test harnesses cutting-edge science and technology to deliver ultrasensitive insights from a noninvasive blood test, thereby improving care and value for patients ...